Article

Accommodating IOL receives NTIOL classification

An accommodating IOL with aspheric optics (Crystalens AO, Bausch + Lomb) has received new-technology IOL classification from the Centers for Medicare and Medicaid Services.

Aliso Viejo, CA

-An accommodating IOL with aspheric optics (Crystalens AO, Bausch + Lomb) has received new-technology IOL (NTIOL) classification from the Centers for Medicare and Medicaid Services (CMS).

The classification became effective April 9 and means that the lens is approved for an additional $50 Medicare payment adjustment for services in conjunction with cataract procedures performed at ambulatory surgical centers.

“We are pleased that the [lens] has been included into the active NTIOL class for reduced spherical aberration,” said Andy Corley, global president, Surgical, Bausch + Lomb. “We believe that this decision should benefit surgeons and their patients in the coming months."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.